24 - 30 September 2016
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
A review of the recent ECTRIMS conference in London includes siponimod, lipoic acid, gut bacteria, fluoxetine failure, vitamin D and smoking, vitamin D and Rebif, biomarkers, home-based rehabilitation, fatigue, pain prevalence, fampridine, cognitive rehab, Arbaclofen for spasticity, Anti-LINGO, myelin repair in paediatric MS, exercise and myelin repair in mice
Source: National MS Society (USA)
MS Trust link: MS in the media - ECTRIMS 2016
Exercise and risk of MS
EMA recommends temporary restriction on use of Lemtrada
12 April 2019
The European Medicines Agency has recommended a temporary restriction on people who should start treatment with Lemtrada while a review of side effects is carried out.
How fundraising for the MS Trust helps me to help my daughter
12 April 2019
Nick is taking part in the Great North Run for the third time in September and this year his daughter Amie will be joining him on Team MS Trust for her first half marathon. Here, Nick and Amie tell us about the inspiration behind their fundraising.